Events - Precision Biologics

06AugAugust 6, 2024

Dr. Philip M. Arlen to Chair and Present at Cambridge Healthtech Institute Immuno-Oncology Summit 2024, August 7-9, 2024, Philadelphia, PA

Precision Biologics’ CEO, Dr. Philip M. Arlen, to Chair Therapeutic Cancer Vaccine Program, and lead...

01AugAugust 1, 2024

Genetic Engineering and Biotechnology News (GEN) news article highlights Precision Biologics, Inc., August 1, 2024...

07FebFebruary 7, 2020

NEO-201 is an IgG1 mAb targeting variants of CEACAM5/6 that demonstrates tumor sensitivity and specificity....

23JanJanuary 23, 2020

This is a first-in-human phase 1 study to determine the maximum tolerated dose (MTD) and...

06NovNovember 6, 2019

27OctOctober 27, 2019

President and...

15OctOctober 15, 2019

Target is broadly expressed in multiple solid tumors. Exhibits both ADCC and CDC...

06AugAugust 6, 2019

Dr. Philip M Arlen, will be representing Precision Biologics in the PLENARY KEYNOTE SESSION, PANEL DISCUSSION:...

30AprApril 30, 2019

Abstract Title: Phase 1 with expansion cohorts in a study of NEO-201 in adults with...

12AprApril 12, 2019

First international congress of

An International multidisciplinary meeting 12-13-14 APRILE 2019 REGGIO CALABRIA ITALY Palazzo della Provincia, Sala...